BNC Korea Co., Ltd. (KOSDAQ:256840)
South Korea · Delayed Price · Currency is KRW 4,800.00
-170.00 (-3.42%)
Oct 10, 2025, 3:30 PM KST
BNC Korea Market Cap
BNC Korea has a market cap or net worth of 328.30 billion as of October 10, 2025. Its market cap has decreased by -10.97% in one year.
Market Cap
328.30B
Enterprise Value
256.72B
Revenue
99.34B
Ranking
n/a
PE Ratio
20.61
Stock Price
4,800.00
Market Cap Chart
Since November 18, 2019, BNC Korea's market cap has increased from 15.37B to 328.30B, an increase of 2,035.47%. That is a compound annual growth rate of 68.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 339.92B | 23.28% |
| Dec 30, 2024 | 275.74B | 12.30% |
| Dec 28, 2023 | 245.55B | -20.03% |
| Dec 29, 2022 | 307.06B | -78.68% |
| Dec 30, 2021 | 1,440.31B | 557.65% |
| Dec 30, 2020 | 219.01B | 174.73% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |